阻害性睡眠無呼吸症の患者におけるC反応性タンパク質の値上昇
Abu S M Shamsuzzaman1, Mikolaj Winnicki, Paola Lanfranchi
1Mayo Clinic Rochester, Rochester, MN 59905, USA.
Circulation
|May 30, 2002
まとめ
阻害性睡眠時無呼吸症候群 (OSA) は,炎症と心血管リスクのマーカーであるC反応性タンパク質 (CRP) のレベルが高いことと関連しています. 高いCRPは,より重度のOSAを示しています.
科学分野:
- 心臓病学 心臓病学
- スリープ・メディシン (睡眠医学)
- 炎症の研究 炎症の研究
背景:
- 阻害性睡眠時無呼吸症 (OSA) は,ますます心血管および脳血管疾患と関連付けられています.
- OSAにおける炎症プロセスは,心血管疾患に寄与する可能性があります.
- この研究では,OSAとC反応性タンパク質 (CRP) レベルとの関連を調査しました.
研究 の 目的:
- OSA患者の血CRP濃度が上昇しているという仮説を検証する.
- OSAの重症度とCRPレベルとの関係を調査する.
主な方法:
- 他の病気や薬剤なしで,OSAと新たに診断された22人の患者を研究しました.
- 20歳のOSA患者におけるCRP濃度を比較し,オカルトOSAのない年齢とBMIにマッチしたコントロールを比較した.
- 独立した関連性を評価するために,多変量分析を使用した.
主要な成果:
- プラズマCRP濃度は,対照群と比較してOSA患者で有意に高かった (中位値は0.33対0.09mg/dL).
- 高濃度のCRPは,独立してOSAの重症度 (P=0.032) と関連していました.
結論:
- 阻害性睡眠時無呼吸症は,C反応性タンパク質 (CRP) レベルが上昇したものと関連しています.
- CRPは,OSA患者の炎症と心血管リスクのマーカーとして機能します.
- OSAの重症度は,CRPレベルと正比例しています.
関連する概念動画
Tonsillitis I: Introduction
3.9K
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Etiology
Three primary contributing factors have been identified.
3.9K
Acute Respiratory Failure-IV
824
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
824
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
Sleep Apnea
914
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
914
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40


